Previous close | 87.00 |
Open | 87.50 |
Bid | 87.50 x 0 |
Ask | 90.00 x 0 |
Day's range | 87.50 - 87.50 |
52-week range | 65.00 - 87.50 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Evaluate the expected performance of Haemonetics (HAE) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
Haemonetics' (NYSE:HAE) stock is up by a considerable 12% over the past month. Given the company's impressive...